News
Shares in Verve Therapeutics (NASDAQ: VERV) soared 80.5% this week on the news of an agreement for Eli Lilly (NYSE: LLY) to ...
Barchart on MSN22h
A $1.3 Billion Reason to Buy Eli Lilly Stock NowEli Lilly (LLY) is a pharmaceutical company that focuses on cardiometabolic health, neuroscience, oncology, and immunology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback